1. Information about the conclusion of a material agreement, 27 July 2011 The Management Board of Trakcja – Tiltra S.A. (hereinafter referred to as: the “Company”) hereby announces that on..
MoreReference is made to the public releases of 24th May 2011 announcing that Valeant Pharmaceuticals International, Inc. (“Valeant”) intends to acquire the entire 87.2% shareholding from the funds advised by..
More1. Information about the conclusion of a material agreement The Management Board of Trakcja – Tiltra S.A. (the “Company”) hereby announces that on 13 July 2011, a subsidiary of the..
MoreReference is made to the public releases of 24th May 2011 announcing that Valeant Pharmaceuticals International, Inc. (“Valeant”) intends to acquire the entire 87.2% shareholding from the funds advised by..
MoreThe Management Board of Trakcja – Tiltra S.A. (the “Company”) hereby announces that pursuant to Article 69 paragraph 1 point 2 of the Act of 29 July 2005 on Public..
MoreThe Management Board of Traction – Tiltra SA (The “Company” or “Contractor”) hereby announces that on 4 July 2011, the Company concluded with Bombardier Transportation (ZWUS) Polska Sp. z o.o…
MoreThe Management Board of Trakcja Polska S.A. (hereinafter: the “Contractor”, the “Company”) wishes to inform that on 30 June 2011 the Company concluded with PKP Polskie Linie Kolejowe S.A. (hereinafter:..
MoreThe Management Board of Trakcja – Tiltra S.A. (the “Company”) would like to inform that on 28 June 2011 the Supervisory Board of the Company adopted a resolution on the..
MoreThe Management Board of Trakcja – Tiltra S.A. with its registered office in Warsaw (“the Company”) hereby publicly announces the wording of the resolutions adopted at the Ordinary General Meeting..
More